Viral diseases can attack and spread quickly as seen with COVID-19. To regain control over transmission and accelerate vaccine development, scientists must be prepared with the adequate tools to produce reliable, quality results for viral identification. More specifically scientists must be able to isolate viral particles to study their morphological and genotypic state to push towards vaccine production and biopharma manufacturing.
Download this app note to discover a selection of solutions targeting:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy